| 臺大學術典藏 |
2021-07-06T02:37:31Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; FANG-JU LIN; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-07-03T03:34:37Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang H.-H.; Shih W.-L.; Li Y.-H.; Wu C.-F.; PEI-JER CHEN; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-02T02:35:17Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Lin S.-Y.; Lin T.-H.; Wang T.-D.; Yeh H.-I.; Chen J.-F.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; WEI-SHIUNG YANG; Ueng K.-C.; Chu P.-H.; Yin W.-H.; Wu Y.-W.; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L. |
| 臺大學術典藏 |
2021-06-28T06:52:23Z |
Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia
|
Lin C.-C.; Hsu Y.-C.; Li Y.-H.; Kuo Y.-Y.; Hou H.-A.; KENG-HSUEH LAN; Chen T.-C.; Tzeng Y.-S.; Kuo Y.-Y.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Chiu Y.-C.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-06-04T08:33:27Z |
1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors
|
Lee H.-Y.; CHIA-RON YANG; Lai M.-J.; Huang H.-L.; Hsieh Y.-L.; Liu Y.-M.; Yeh T.-K.; Li Y.-H.; Mehndiratta S.; Teng C.-M.; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:27Z |
Inside Cover: 1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors (ChemBioChem 10/2013)
|
Lee H.-Y.; CHIA-RON YANG; Lai M.-J.; Huang H.-L.; Hsieh Y.-L.; Liu Y.-M.; Yeh T.-K.; Li Y.-H.; Mehndiratta S.; Teng C.-M.; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:25Z |
Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009
|
Hsieh I.-N.; Liou J.-P.; Lee H.-Y.; Lai M.-J.; Li Y.-H.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:24Z |
3-Aroylindoles display antitumor activity in?vitro and in?vivo: Effects of N1-substituents on biological activity
|
Lee H.-Y.;Lee J.-F.;Kumar S.;Wu Y.-W.;Huangfu W.-C.;Lai M.-J.;Li Y.-H.;Huang H.-L.;Kuo F.-C.;Hsiao C.-J.;Cheng C.-C.;Chia-Ron Yang;Liou J.-P.; Lee H.-Y.; Lee J.-F.; Kumar S.; Wu Y.-W.; HuangFu W.-C.; Lai M.-J.; Li Y.-H.; Huang H.-L.; Kuo F.-C.; Hsiao C.-J.; Cheng C.-C.; CHIA-RON YANG; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:24Z |
Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma
|
Chen M.-C.; Huang H.-H.; Lai C.-Y.; Lin Y.-J.; Liou J.-P.; Lai M.-J.; Li Y.-H.; Teng C.-M.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:24Z |
2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase
|
Lee H.-Y.; Chang C.-Y.; Su C.-J.; Huang H.-L.; Mehndiratta S.; Chao Y.-H.; Hsu C.-M.; Kumar S.; Sung T.-Y.; Huang Y.-Z.; Li Y.-H.; CHIA-RON YANG; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:23Z |
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo
|
Lee H.-Y.; Nepali K.; Huang F.-I.; Chang C.-Y.; Lai M.-J.; Li Y.-H.; Huang H.-L.; CHIA-RON YANG; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:22Z |
5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes
|
Lee H.-Y.; Fan S.-J.; Huang F.-I.; Chao H.-Y.; Hsu K.-C.; Lin T.E.; Yeh T.-K.; Lai M.-J.; Li Y.-H.; Huang H.-L.; CHIA-RON YANG; Liou J.-P. |
| 臺大學術典藏 |
2021-05-31T06:17:53Z |
Single allele Lmbrd1 knockout results in cardiac hypertrophy
|
Tseng L.T.-L.; Lin C.-L.; Pan K.-H.; Tzen K.-Y.; MING-JAI SU; Tsai C.-T.; Li Y.-H.; Li P.-C.; Chiang F.-T.; Chang S.C.; Chang M.-F. |
| 臺大學術典藏 |
2021-05-28T02:07:26Z |
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity
|
Peng, C., Li, Y,.-H. Yu, C.-W., Cheng, J.-H., Liu, J.-R., Hsu, J.-L., Hsin, L.-W., Huang, C.-T.,?Juan, H.-F., Chern, J.-W., Cheng, Y.-S.; Peng, C.; Li, Y.-H.; Yu, C.-W.; Cheng, J.-H.; Liu, J.-R.; Hsu, J.-L.; Hsin, L.-W.; Huang, C.-T.; Juan, H.-F.; Chern, J.-W.; Cheng, Y.-S. |
| 臺大學術典藏 |
2021-05-21T07:46:13Z |
Evolutionary trajectories and genomic divergence in localized breast cancers after ipsilateral breast tumor recurrence
|
Wu C.-H.; Yeh H.-T.; Hsieh C.-S.; Huang C.-C.; Chattopadhyay A.; Chung Y.-C.; Tu S.-H.; Li Y.-H.; TZU-PIN LU; Lai L.-C.; Hou M.-F.; Chang K.-J.; Tsai M.-H.; Chuang E.Y. |
| 臺大學術典藏 |
2021-05-21T01:54:02Z |
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity
|
Peng C.; Li, Y.H.; Yu, C.W.; Cheng, Z.H.; Liu, J.R.; Hsu, J.L.; Hsin, L.W.; Huang, C.T.; Juan, H.F.; Chern, J.W.; Cheng, Y.S. |
| 臺大學術典藏 |
2021-05-20T02:30:47Z |
A flavin monooxygenase-like overexpression mutant with narrow, down-curing and long petioles phenotypes in?Arabidopsis
|
Li Y.H. and Jinn T.L.; Li Y.H.; Jinn T.L. |
| 臺大學術典藏 |
2021-05-18T07:11:43Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang H.-H.;Wei-Liang Shih ;Li Y.-H.;Wu C.-F.;Chen P.-J.;Lin C.-L.;Liu C.-J.;Liaw Y.-F.;Lin S.-M.;Lee S.-D.;Yu M.-W.; Huang H.-H.; WEI-LIANG SHIH; Li Y.-H.; Wu C.-F.; Chen P.-J.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:28Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:21Z |
The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients
|
Lin G.-M.; Li Y.-H.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Wang C.-C.; Yeh S.-J.; Lin W.-S.; Chan K.-C.; Chang H.-C.; Chang K.-C.; Chen Z.-C.; Chen S.-M.; Chu P.-H.; Hsu C.-H.; Huang J.-L.; Kuo J.Y.; Lin J.-L.; Lin W.-S.; Mar G.-Y.; Shyu K.-G.; Sung S.-H.; Tseng W.-K.; Voon W.-C.; Wang J.-H.; Wen M.-S.; Yang N.-I. |
| 臺大學術典藏 |
2021-03-18T08:54:15Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Lin S.-Y.; Lin T.-H.; Wang T.-D.; Yeh H.-I.; Chen J.-F.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L. |
| 臺大學術典藏 |
2021-03-18T08:54:13Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:11Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; YEN-WEN WU; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:02Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:02Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; YEN-WEN WU; Hwang J.-J.; Lin J.-L. |
